A detailed history of Qube Research & Technologies LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,226,637 shares of TEVA stock, worth $27.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,226,637
Previous 2,083,999 41.14%
Holding current value
$27.1 Million
Previous $33.9 Million 34.73%
% of portfolio
0.03%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $13.6 Million - $16.3 Million
-857,362 Reduced 41.14%
1,226,637 $22.1 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $25.8 Million - $35.2 Million
2,022,219 Added 3273.26%
2,083,999 $33.9 Million
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $659,192 - $891,485
61,780 New
61,780 $871,000
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $1.63 Million - $2.15 Million
226,841 Added 16.3%
1,618,232 $12.2 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $11.6 Million - $15.8 Million
1,391,391 New
1,391,391 $12.3 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $13.3 Million - $23.1 Million
1,933,334 Added 682.55%
2,216,584 $17.9 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $2.09 Million - $2.95 Million
283,250 New
283,250 $2.13 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $2.92 Million - $3.54 Million
-348,175 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $3.45 Million - $4.02 Million
348,175 New
348,175 $3.45 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $518,287 - $664,563
-60,196 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $998,293 - $1.48 Million
-116,487 Reduced 65.93%
60,196 $542,000
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $1.43 Million - $2.32 Million
176,683 New
176,683 $2.18 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.